NCT06522256View on ClinicalTrials.gov

Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial

NANot yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

February 6, 2025

Primary Completion Date

July 30, 2027

Study Completion Date

July 30, 2027

Conditions

HPV InfectionAnal Cancer

Interventions

PROCEDURE

High-resolution anoscopy

"The study includes 2 visits:~* a medical consultation for inclusion~* a proctology consultation including the performance of an AHR associated or not with biopsy sampling"

Trial Locations (3)

69004

Hôpital de la Croix Rousse - SMIT, Lyon

75010

Hôpital Saint-Louis - SMIT, Paris

75020

Hôpital Tenon - SMIT, Paris

All Listed Sponsors

collaborator

INSERM SC10-US19

UNKNOWN

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV